AVANT DIAGNOSTICS INC Instrumento Inactivo
Empresa Avant Diagnostics Inc
Acciones
US05350M1062
Biotecnología e investigación médica
|
Precio de cierre
Otros sitios de cotización
|
||
| - USD | - |
|
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/12/17 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 24/09/20 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/16 |
Trevor McCartney
PRN | Corporate Officer/Principal | - | 01/03/19 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 25/05/18 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 01/12/17 |
| Director/Board Member | 43 | - | |
| 51 | - | ||
Yvonne Fors
BRD | Director/Board Member | 52 | 01/01/00 |
Matthew Schwartz
BRD | Director/Board Member | 50 | - |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 336 957 722 | 9 119 130 ( 2,706 %) | 0 | 2,706 % |
Participaciones
| Nombre | Acciones | % | Valoración |
|---|---|---|---|
THERALINK TECHNOLOGIES, INC. 100.00% | 1 000 | 100.00% | 1 $ |
Información de la empresa
Theralink Technologies, Inc. (Colorado)
15000 West 6th Avenue Suite 400
80401, Golden
+
https://theralink.com
Sector
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -31,06 % | 9296,61 M | |
| -8,43 % | 3103,28 M | |
| +27,31 % | 2865,49 M | |
| -14,31 % | 2169,93 M | |
| -18,94 % | 1749,13 M | |
| +73,13 % | 1503,65 M | |
| +30,25 % | 807 M | |
| -1,97 % | 759 M | |
| -26,73 % | 532 M |
- Bolsa de valores
- Acciones
- Acción
- Empresa Avant Diagnostics Inc